Farther Finance Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Buy
17,304
+14,722
+570% +$292K ﹤0.01% 1865
2026
Q1
$50.3K Sell
2,582
-3,106
-55% -$61.2K ﹤0.01% 2990
2025
Q4
$108K Buy
5,688
+1,736
+44% +$32.2K ﹤0.01% 2306
2025
Q3
$73.7K Buy
3,952
+3,449
+686% +$64.4K ﹤0.01% 2223
2025
Q2
$9.27K Buy
503
+139
+38% +$2.47K ﹤0.01% 3114
2025
Q1
$6.37K Buy
364
+27
+8% +$455 ﹤0.01% 2942
2024
Q4
$5.84K Sell
337
-93
-22% -$1.7K ﹤0.01% 2601
2024
Q3
$7.99K Buy
430
+43
+11% +$725 ﹤0.01% 2455
2024
Q2
$5.96K Buy
387
+175
+83% +$2.5K ﹤0.01% 2320
2024
Q1
$3.12K Sell
212
-662
-76% -$9.17K ﹤0.01% 2298
2023
Q4
$12.5K Buy
874
+207
+31% +$2.94K ﹤0.01% 1520
2023
Q3
$9.3K Buy
+667
New +$8.53K ﹤0.01% 1309

Other funds holding SBRA

Farther Finance Advisors's SBRA Position: Q2 2026 in Review

Farther Finance Advisors increased its Sabra Healthcare REIT (SBRA) stake by 570% in Q2 2026, buying an estimated $292K and bringing the position to 17,304 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Farther Finance Advisors first reported a position in SBRA in Q3 2023 and has held it in 12 quarters since. 39 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Farther Finance Advisors held 17,304 shares of Sabra Healthcare REIT worth $338K as of Q2 2026.
  • Farther Finance Advisors bought 14,722 Sabra Healthcare REIT shares in Q2 2026, an estimated $292K.
  • Sabra Healthcare REIT made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1865 holding.
  • Farther Finance Advisors first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 12 quarters since.
  • 39 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.